Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.391NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.448NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Q.1 (Alpha)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.46 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.99 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.120.2 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.528NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-18512.9China
C.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.91 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.39NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.617NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.54NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.196NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.57NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.34NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.459NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.117NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.381NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.237NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.382NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.2.3.17NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FD.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.44NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.26NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GN.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FW.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FY.1.2.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBLNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EK.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.466.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.10.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GS.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HG.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.323NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FU.1.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FY.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FN.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.74NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.53NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JB.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
A.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XDK.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.58NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-5048.56China
BA.4.1.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.3.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GA.10.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KC.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used